| Dustin Tolley, PT | |
|
3301 Stockdale St, Suite B, Mount Pleasant, SC 29466-7125 | |
| (843) 375-5448 | |
| Not Available |
| Full Name | Dustin Tolley |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 3301 Stockdale St, Mount Pleasant, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124367107 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 6943 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dustin Tolley, PT 325 Midland Pkwy, Apt 811, Summerville, SC 29485-8172 Ph: () - | Dustin Tolley, PT 3301 Stockdale St, Suite B, Mount Pleasant, SC 29466-7125 Ph: (843) 375-5448 |
News Archive
The New Jersey Department of Health and Senior Services Commissioner Fred M. Jacobs, M.D., J.D. has launched an educational campaign to inform expectant mothers of the life-saving value of newborn umbilical cord and placental blood.
In a U.S. and Swiss study, nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose, but the fact that a small group of the patients exhibited no response raised questions about how their protection against the virus will be addressed moving forward.
Puma Biotechnology, Inc., a development stage biopharmaceutical company, announced that results from an ongoing Phase I clinical trial of its lead drug candidate PB272 (neratinib) given in combination with the anticancer drugs paclitaxel and trastuzumab in patients with metastatic HER-2 positive breast cancer were presented in a poster presentation at the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting.
Jennerex, Inc., a clinical-stage biotherapeutics company focused on the development of first-in-class, targeted oncolytic products for cancer, today reported positive interim data from a pilot trial using JX-594 followed by sorafenib (Nexavar®) to treat liver cancer patients. The data were presented today at the Fourth Annual International Liver Cancer Association Conference in Montreal, Canada.
› Verified 4 days ago
Alison Morris Schryver, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 401 Seacoast Pkwy Unit D, Mount Pleasant, SC 29464 Phone: 843-969-2201 Fax: 843-969-2202 | |
Mrs. Mariesa Eikevik, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3559 Franklin Tower Dr, Mount Pleasant, SC 29466 Phone: 571-244-7206 Fax: 854-227-5165 | |
Go Pt Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2911 Old Tavern Ct, Mount Pleasant, SC 29466 Phone: 843-609-0123 | |
Kelli Whitsitt, MSR, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1535 Barquentine Dr, Mount Pleasant, SC 29464 Phone: 843-270-1594 | |
Deanna Smoak, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 320 W Coleman Blvd Ste B, Mount Pleasant, SC 29464 Phone: 843-823-5133 Fax: 843-806-4997 | |
Ms. Heather Nicole Chumley-jones, MSRPT, RYT200 Physical Therapist Medicare: Medicare Enrolled Practice Location: 3409 Salterbeck Ct, Suite 202, Mount Pleasant, SC 29466 Phone: 843-972-0671 | |
Coastal Carolina Physical Therapy Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 3014 S Morgans Pt Rd Ste D, Mount Pleasant, SC 29466 Phone: 843-284-8092 |